Skip to content

Apotheek Vermylen

Active Private limited companyfounded 1980active for 46 yearsLeo Kempenaersstraat 7, 2223 Heist-op-den-BergKBO/BCE: BE 0420.633.867 subsidiary of

Lifetime

20 annual accounts with figures on one time axis, 46 filings since 1980
peak of €476,665 in 2025
€476,665▲ 9.9%
peak of €234,765 in 2025
€234,765▲ 10.6%
peak of €590,324 in 2017
€423,279unchanged
€646,495▲ 39.9%
peak of 15 FTE in 2010
1.4 FTEunchanged
Board2 names since 2017
2 directors and 1 other
Owners
99.82%
Documentsfilings and deeds
03-07-202628 days before the deadline
2025abbreviated format
Dividend €234,765Debts from €462,153 to €646,495

Key points

from the 2025 annual accounts

Equity

€423,279 =
423,2792024+234,765Profit-234,765Dividend423,2792025

Apotheek Vermylen paid out €234,765 in dividends. That is 100% of the 2025 profit.

Turnover

≈ €1.6m estimated

The abbreviated format states no turnover.

Debts

€646,495 ▲ 39.9%
Other debts
+111,800
Suppliers
+92,202
The rest
-19,659

Debts rose by €184,342 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.

Staff

1.4 FTE from 15 in 2010

Between 2010 and 2025, the number of full-time equivalents fell by 91%.

Filings

46 annual accounts since 1980
AprilJune31 JulyOctober1980199520102025

Three of the last ten came late. The 2019 accounts came in latest, 28 days after the end of the period.

Position in the sector

€234,765

Higher net result than 88% of companies in retail trade. The sector median is €37,977, over 13,310 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,390 companies had the same profile as Apotheek Vermylen has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,390 companies, not a prediction for Apotheek Vermylen. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director,
Director
  • 99.82%score equity €1.0m (2025) · annual accounts 2025 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0420633867
Company renamed to Apotheek Vermylen (director) and (director) change roles · acts as permanent representative · Discharge granted to · Gazette deed
New manager appointed, resigned · acts as permanent representative · Gazette deed
Capital increase of €202,500 to €301,657.40 The capital rose from €99,157.40 to €301,657.40, with 5,217 new shares · Contribution by · General meeting of 17-12-2013 · Gazette deed
All 58 events

Comparable companies

same main activity, similar in size and age
Company
Apotheek Vermylen Heist-op-den-Berg €1.1m €476,665 39.6% 1.4
APOTHEEK PUURSFARMA Puurs-Sint-Amands €1.1m €518,521 12.5% 1.7
Apotheek Bontinck Wichelen €1.2m €442,559 81.9% 1.6
APOTHEEK DASSEN Scherpenheuvel-Zichem €1.2m €558,999 16.3% 1.5
APOTHEEK PROOSTERBOS Maasmechelen €1.1m €458,885 18.1% 1.5
APOTHEEK MAES KATRIEN Kortrijk €1.2m €359,650 1.9% 1.2
APOTHEEK PUTTEMANS-VERNAILLEN Putte €1.2m €413,332 75.1% 2

These companies have the same main activity as Apotheek Vermylen: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.1m and €1.2m, founded between 1983 and 1991.

Official details

Source: KBO
Status
Active since 18-08-1980Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.017.933.8572223 Heist-op-den-Berg, since 18-08-1980
Financial year end
31 December
Peppol
Reachable since 24-11-2023
Company details

Annual accounts 2025

€1.1m▲ 20.8%
Employeeson 31-12-2025
2=
Filing
Filed on 03-07-2026, 28 days before the end of the filing period
Financials

Insights on Apotheek Vermylen

Apotheek Vermylen files the abbreviated format. That format states no turnover. The gross margin rose from €205,515 in 2006 to €476,665 in 2025.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Apotheek Vermylen

What is the company number of Apotheek Vermylen?
The company number of Apotheek Vermylen is 0420.633.867. The VAT number is the same number with BE in front: BE 0420.633.867.
Where is Apotheek Vermylen based?
The registered office is at Leo Kempenaersstraat 7, 2223 Heist-op-den-Berg.Company details
What does Apotheek Vermylen do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Vermylen?
Apotheek Vermylen is a private limited company (BV).
When was Apotheek Vermylen founded?
Apotheek Vermylen was founded on 18-08-1980.
Is Apotheek Vermylen still active?
Yes, Apotheek Vermylen is an active enterprise in the KBO register.
How many employees does Apotheek Vermylen have?
Apotheek Vermylen had an average of 1.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek Vermylen?
The turnover in financial year 2025 is about €1.6m. This figure is estimated from the gross margin of €476,665 and 42 comparable companies (NACE 477). It probably lies between €1.3m and €2.3m.
Is Apotheek Vermylen profitable?
In financial year 2025, Apotheek Vermylen made a profit of €234,765.
Where can I find the annual accounts of Apotheek Vermylen?
Apotheek Vermylen filed 46 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek Vermylen due?
Apotheek Vermylen must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.